Twin to Twin Transfusion Syndrome

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

One Biosciences
One BiosciencesFrance - Paris
1 program
S-LPC:Selective Laser PhotocoagulationN/A1 trial
Active Trials
NCT02506049CompletedEst. Oct 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
One BiosciencesS-LPC:Selective Laser Photocoagulation

Clinical Trials (1)

NCT02506049One BiosciencesS-LPC:Selective Laser Photocoagulation

Laser Photocoagulation in Twin to Twin Transfusion Syndrome

Start: Apr 2010Est. completion: Oct 2020
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space